Sareum Holdings plc (AIM: SAR), the specialist structure-based drug discovery business, is pleased to announce that it has entered into a second collaborative agreement with H. Lundbeck A/S (Copenhagen: LUN), an international pharmaceutical company with sales of approx. €1.2 Billion in 2005, to provide protein structure determination capabilities to accelerate drug discovery research at Lundbeck.
